Paladin Labs Inc. is a specialty pharmaceutical company focused on developing, acquiring, in-licensing, marketing and distributing pharmaceutical products. The Company�s product portfolio includes Tridural, Abstral and Trelstar. Tridural is a once-a-day tramadol product indicated as a first-line therapy for adults with moderate pain requiring several days or more of treatment. Abstral is a sublingual tablet used for the management of breakthrough cancer pain in patients who are already tolerant to other opioid analgesics. Trelstar is an injectable, luteinizing hormone releasing hormone agonist indicated for the palliative treatment of prostate cancer and endometriosis. In February 2011, the Company acquired the Tempra line of products in Canada from Bristol-Myers Squibb. In November 2011, it acquired the rights to Travelan in Canada, Latin America and Sub-Saharan Africa. Effective January 1, 2013, the Company acquired Ativa Pharma S.A.